Clinical Study
Partial Splenic Embolization with Transarterial Chemoembolization in Patients with Hepatocellular Carcinoma Accompanied by Thrombocytopenia
| | | | | Any grade number (%) | ≥grade 3 number (%) |
| Increased AST/ALT levels | 24 (75) | 9 (28) | Pain | 19 (59) | 0 | Increased ALP level | 15 (46) | 0 | Ascites | 14 (44) | 0 | Increased bilirubin level | 11 (34) | 2 (6) | Anorexia | 6 (19) | 0 | Pleural effusion | 5 (16) | 0 | Fever | 4 (13) | 0 | Decreased leukocyte counts | 3 (9) | 2 (6) | Increased PT-INR | 3 (9) | 2 (6) | Hyperkalemia | 3 (9) | 1 (3) | Hypocalcemia | 3 (9) | 0 | Constipation | 3 (9) | 0 | Increased CPK level | 3 (9) | 0 | Decreased neutrocyte counts | 2 (6) | 2 (6) | Hyperuricemia | 2 (6) | 1 (3) | Nausea | 2 (6) | 0 | Diarrhea | 2 (6) | 0 | Hematoma | 2 (6) | 0 | Increased creatinine level | 2 (6) | 0 | Hepatic failure | 1 (3) | 1 (3) | Portal vein thrombosis | 1 (3) | 1 (3) | Splenic abscess | 1 (3) | 0 | Splenic rupture | 0 | 0 | Pneumonia | 0 | 0 |
|
|
AST, aspartate aminotransferase; ALT, alanine aminotransferase; ALP, alkaline phosphatase; PT-INR, prothrombin time-international normalized ratio; CPK, creatine phosphokinase.
|